Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Iran J Med Sci ; 48(6): 582-590, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-38094286

RESUMEN

Background: Although antihistamines are the first-line treatment for chronic spontaneous urticaria (CSU), 50% of patients don't respond to standard doses. In this study, the effectiveness of Ziziphus jujube fruit syrup in combination with antihistamines was assessed in patients with CSU. Methods: This double-blind randomized clinical trial was conducted in Shiraz between December 2019 and December 2020. 64 patients with CSU who had experienced hives for at least six weeks and did not respond to the usual treatments were enrolled in the study. They were randomly assigned to intervention and control groups using permuted block random allocation. For four weeks, the intervention group received 7.5 mL Ziziphus jujube syrup twice a day, while the control group received 7.5 mL simple jujube syrup twice a day. Both groups received cetirizine 10 mg every night. Urticaria activity score (UAS) and CU-Q2oL questionnaires were used to assess urticaria state and sleep quality before and after each week for four consecutive weeks. Data were analyzed using SPSS software version 18, and P<0.05 was considered statistically significant. Results: Before the intervention, there was no statistically significant difference between the two groups' mean of UAS (P=0.490) and sleep quality (P=0.423). During the follow-up, UAS in the intervention group was significantly lower (P=0.001). Moreover, this difference was significant on the day 28 (P=0.046). During the follow-up, the quality of sleep in both groups improved significantly, and this improvement was more significant in the intervention group. Conclusion: Ziziphus jujube syrup could be an effective adjuvant treatment for CSU.Trial Registration Number: IRCT20190304042916N1.


Asunto(s)
Urticaria Crónica , Urticaria , Ziziphus , Humanos , Enfermedad Crónica , Antagonistas de los Receptores Histamínicos H1/farmacología , Antagonistas de los Receptores Histamínicos H1/uso terapéutico , Urticaria Crónica/tratamiento farmacológico , Urticaria/tratamiento farmacológico
2.
Iran J Psychiatry ; 9(4): 248-52, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25792994

RESUMEN

OBJECTIVE: The most commonly used instrument for the research and treatment of excessive internet use is Young's Internet Addiction Test (IAT). While the IAT has been translated to several languages (including Persian) and has demonstrated good psychometric properties across several independent studies, there is still a room for alternative assessment instruments. This study reports a validation of the Persian version of the Problematic Internet Use Questionnaire (PIUQ). METHOD: A sample (n = 296) from Kerman, Iran was administered the translated Persian version of the PIUQ as well as the Persian version of the University of California, Los Angeles (UCLA) Loneliness scale, Satisfaction With Life scale, and questions related to use of technology and the internet. RESULTS: Analyses using confirmatory and exploratory factor analyses demonstrated that the Persian version of the PIUQ had good internal reliability and concurrent validity (with loneliness and satisfaction with life), but they also had an alternative factor structure that did not support the original factor structure. CONCLUSION: The Persian version of the PIUQ produced adequate psychometric properties (internal reliability and concurrent validity), but care should be taken in the interpretation of the factor structure.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...